Kronos Bio Inc

NASDAQ:KRON  
1.43
+0.16 (+12.60%)
7:50:40 PM EDT: $1.43 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)96.76M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.53 Million
Adjusted EPS-$0.36
See more estimates
10-Day MA$1.24
50-Day MA$1.02
200-Day MA$1.10
See more pivots

Kronos Bio Inc Stock, NASDAQ:KRON

1300 So. El Camino Real, Suite 300, San Mateo, California 94402
United States of America
Phone: +1.650.781.5200
Number of Employees: 63

Description

Kronos Bio, Inc. is a clinical development biopharmaceutical company. It engages in the business of developing therapeutics that target dysregulated transcription that causes cancer and other serious diseases. The company was founded by Arie S. Belldegrun, Joshua A. Kazam, David M. Tanen, and Christopher Wilfong on June 2, 2017 and is headquartered in San Mateo, CA.